MedTrace Logo

Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris

NCT02219074 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2017-09-07

No results posted yet for this study

Summary

Prospective, multicenter study with multiple arms to examine the safety and effectiveness of the Sebacia Acne Treatment System for the treatment of acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

DEVICE

Sebacia microparticle and laser treatment

DEVICE

Vehicle and laser treatment

Sponsors & Collaborators

  • Sebacia, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02219074 on ClinicalTrials.gov